We open with a fast, curated tour of the converging technologies reshaping health and medicine, so everyone shares the same map of what's possible.

Topics include: AI and agents, robotics, synthetic biology, multi-omics, quantum computing, regenerative medicine, wearables, and what's coming over the horizon.

AI is moving from pilots into the daily fabric of care, research, and health itself. We look at where it's delivering, where the hype runs ahead, and what responsible scale requires.

Topics include: ambient and agentic AI in the clinic, AI-native diagnostics, digital twins, AI for patients and caregivers, and trust, safety, and governance.

Item descWe are on the cusp of a healthspan revolution. We separate hype from hope on what extends healthy years now, and on what's coming to slow or even reverse aging.

Topics include: the science of aging, biomarkers and aging clocks, prevention and precision nutrition, regenerative medicine, and healthspan at population scale.ription

Care is shifting to the home, the phone, and the body. We explore the new models, tools, and incentives redefining where, when, and how care happens.

Topics include: virtual-first care, remote monitoring and digital biomarkers, hospital at home, digital therapeutics, the future of surgery and intervention, and connecting the data to the workflow.

From early detection to personalized vaccines, oncology is where many frontier technologies converge first. We bring together clinicians, scientists, and patients to explore what's changing.

Topics include: multi-cancer early detection, cell and gene therapies, AI in pathology and imaging, personalized cancer vaccines, and the patient voice.

Item Long underfunded and understudied, women's health is now one of the fastest-moving areas of innovation. We explore the science, tools, and care models closing the gap.

Topics include: sex-specific research and data, maternal health, menopause and midlife care, women's heart and brain health, and femtech.description

We’re at the $100 genome today, on our way to $10 genomes, and similar lower cost access to a widening array of ‘Ones: From proteome, microbiome, exposome, to sociome and beyond.

How can we leverage the integration of this data into clinical workflows, and actionable insights for personalized drug development, diagnostics and therapy?

AI, multi-omics, and new trial models are compressing the path from discovery to patient. We look at how cures will be found, tested, regulated, and delivered.

Topics include: AI-driven drug discovery, genomics to multi-omics, mRNA and programmable medicines, reimagining clinical trials and regulation, and precision therapeutics.

Neuroscience, technology, and new therapeutics are opening frontiers in how we understand and care for the brain.

Topics include: precision psychiatry and neurology, brain-computer interfaces, psychedelic medicine, digital mental health, and neurodegeneration.

The Future of Intervention: Robotic surgery, to AI & AR enhanced procedures

AR/VR/Mixed Reality enhanced surgical training and interventions

Who and how do we select the next generation of clinicians, and how do we train them and continue to educate?

What should CME look like in the Future?

How can GenAI enhance learning and upskill clinicians and caregivers of all types

Human, community, and planetary health are increasingly intertwined. We examine how frontier technologies can extend access and resilience across the globe.

Topics include: AI and diagnostics for low-resource settings, pandemic preparedness, climate and health, food as medicine, and health equity and access.

Healthy Communities: From the ‘Digital Determinants’ to Social Determinants of Health. The power of connection.

#PatientsIncluded / #NursesIncluded/#CareGivers Included: Upskilling and enabling the entire ecosystem


New institutes, philanthropy, and investment models are changing how breakthroughs get funded and scaled. We hear from the people reshaping the pathway from idea to impact.

Topics include: the new research institutes, the investor lens on what's next, novel funding and incentive models, and spotlights on Innovation Lab startups and MEDy Award winners.

Innovation Lab: Meet 60 leading-edge startups, with many competing for a MEDy Award, with winners featured on the MainStage.

The MEDiverse: Haptics to Avatars, Extending care to the home, clinic and globe

Medical Extended Reality, to Virtual Therapeutics across care, to MedEd are all being enabled by increasingly powerful tools.

How can we further leverage them across the healthcare continuum?

Woven throughout the program, artists, musicians, magicians, and storytellers spark imagination and remind us that the future of health is profoundly human.